Clinical-stage antibody company Generate:Biomedicines is the latest biotech to mull going public as momentum for IPOs continues to build. The Flagship-founded biotech has yet to set out how many ...
How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Champions League permutations: What every team needs to qualify for the round of 16 or the playoffs?
The Champions League league phase is coming to an end. In a breath-stopping final matchday, with all 18 games kicking off simultaneously, almost everything is still up for grabs. The only certainties ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results